Pelin Ergun
Overview
Explore the profile of Pelin Ergun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ergun P, Samuels T, Mathison A, Plehhova K, Coyle C, Horvath L, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409043
Breakthrough symptoms are thought to occur in roughly half of all gastroesophageal reflux disease (GERD) patients despite maximal acid suppression (proton pump inhibitor, PPI) therapy. Topical alginates have recently been...
2.
Ergun P, Kipcak S, Gunel N, Yildirim Sozmen E, Bor S
World J Gastrointest Surg
. 2024 Apr;
16(3):871-881.
PMID: 38577078
Background: Currently, the primary treatment for gastroesophageal reflux is acid suppression with proton pump inhibitors, but they are not a cure, and some patients don't respond well or refuse long-term...
3.
Ergun P, Kipcak S, Gunel N, Bor S, Sozmen E
J Neurogastroenterol Motil
. 2023 Nov;
30(3):290-302.
PMID: 37957115
Background/aims: Gastroesophageal reflux disease is frequently observed and has no definitive treatment. There are 2 main views on the pathogenesis of gastroesophageal reflux disease. The first is that epithelial damage...
4.
Gorgulu V, Ergun P, Kipcak S, Doganavsargil B, Sifrim D, Bor S
J Neurogastroenterol Motil
. 2023 Oct;
29(4):436-445.
PMID: 37814434
Background/aims: Dilated intercellular spaces (DISs) facilitate the diffusion of noxious agents into the deep layers of the esophageal epithelium. The role of DIS in heartburn pathogenesis is still controversial. Therefore,...
5.
Ergun P, Kipcak S, Bor S
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175524
Barrett's esophagus (BE) is a disease entity that is a sequela of chronic gastroesophageal reflux disease that may result in esophageal adenocarcinoma (EAC) due to columnar epithelial dysplasia. The histological...
6.
Demirciler E, Danis N, Ergun P, Kose T, Turan I, Gunsar F, et al.
Hepatol Forum
. 2023 Feb;
4(1):19-24.
PMID: 36843898
Background And Aim: Hepatic encephalopathy (HE) is a frequent complication of liver diseases. Systemic inflammation is key for HE pathogenesis. The main goal of the study was to investigate the...
7.
Kipcak S, Caganoglu D, Ergun P, Bor S
Turk J Gastroenterol
. 2022 Apr;
33(3):257-270.
PMID: 35410859
Background: Gastroesophageal reflux disease has a high incidence of 23%, with 29% of those with gastroesophageal reflux disease consuming nonsteroidal anti-inflammatory drugs. There are insufficient data concerning the effects of...
8.
Ergun P, Kipcak S, Dettmar P, Fisher J, Woodcock A, Bor S
J Clin Gastroenterol
. 2021 May;
56(6):512-517.
PMID: 34049376
Goal: The aim of this study was to investigate the pepsin values and pH results of gastric juice among the subtypes of gastroesophageal reflux disease (GERD) and functional heartburn. Background:...
9.
10.
Bor S, Ergun P, Kipcak S
Clin Gastroenterol Hepatol
. 2016 Sep;
15(2):319-320.
PMID: 27670381
No abstract available.